1. Pfizer Launched its Zirabev (biosimilar, bevacizumab) in the US by the year end 2019
Date - Oct 01, 2019
Product - Zirabev (biosimilar, bevacizumab)
The biosimilar was launched in the US on Dec 31, 2019 following the settlement between Genentech and Pfizer granting all global rights of the product to the Pfizer. In Sept 2019,…
